CenterBook Partners’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
CenterBook Partners's FOLD Position: Q2 2026 in Review
CenterBook Partners sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 153,849 shares — an estimated $2.22M sold.
CenterBook Partners first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $2.22M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.
- CenterBook Partners reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- CenterBook Partners sold 153,849 Amicus Therapeutics shares in Q2 2026, an estimated $2.22M.
- CenterBook Partners first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
- CenterBook Partners's Amicus Therapeutics position peaked at $2.22M in Q1 2026.
- 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.